Skip to playerSkip to main content
  • 2 weeks ago
Recent findings from a study affiliated with Oxford suggest that the Shingrix shingles vaccine, previously linked to a lower incidence of dementia, is also associated with a diminished risk of heart disease. By examining health records of individuals who received the shingles vaccine, researchers observed that those inoculated with the recombinant version experienced fewer occurrences of heart attacks, strokes, and heart failure compared to similarly aged and healthy unvaccinated individuals. These results contribute to the accumulating evidence that a vaccine aimed at alleviating a painful skin condition may offer unforeseen cardiovascular and neurological advantages.
Disclosure:
This video contains stock footage and content created or enhanced using AI-assisted tools.

ai-generated

Category

🗞
News
Transcript
00:00A vaccine already linked to a lower dementia risk may now be protecting your heart, too.
00:05New research from an Oxford-affiliated team finds that the newer shingles vaccine,
00:09known as Shingrix, is tied to a reduced risk of heart disease.
00:13Using a method researchers call a natural experiment,
00:16the team compared health outcomes in people who got the vaccine against those who didn't,
00:21controlling for age and other factors that usually make this kind of research hard to trust.
00:25The results showed vaccinated adults were less likely to suffer heart attacks,
00:30strokes, or heart failure than their unvaccinated peers.
00:33This builds on earlier findings from the same research group
00:37linking the vaccine to a lower dementia risk, reported two years ago.
00:41Scientists say it's now looking like Shingrix may be the first vaccine shown
00:45to protect both the heart and the brain.
00:48Though they stress more research is still needed to fully explain why.
00:51Disclosure. This video contains stock footage and content created or enhanced using AI-assisted tools.
Comments

Recommended